CClinicalTrials.gg
Not yet recruitingNCT07513584DREAMSUpdated Apr 7, 2026

Dual-track Residential Exercise With AI and Monitoring for Sleep

An interventional study of Fit Mirror-Guided Home-Based Exercise Program in Chronic Insomnia Characterized, Difficulty Falling Asleep and Difficulty Maintaining Sleep, sponsored by National Sun Yat-sen University. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by National Sun Yat-sen University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Study summary

As societies rapidly transition toward aging demographics, sleep issues among community-dwelling older adults have emerged as a critical concern affecting healthy aging and independent living. Current single-track exercise intervention models are often difficult to implement due to suboptimal adherence. Therefore, this study aims to utilize artificial intelligence technology combined with a dual-track residential exercise mode to improve sleep quality, thereby enhancing the self-care and independent living abilities of the elderly

Read the detailed description

The DREAMS Study addresses the critical public health challenge of chronic insomnia among community-dwelling older adults (aged ≥60), which substantially impacts healthy aging and independent living. Traditional exercise interventions often suffer from suboptimal adherence and rely on subjective self-reporting that fails to capture the physiological "mismatch" between perceived and actual sleep. To get around these problems, this study uses a home-based, closed-loop, dual-track exercise recommendation model that combines wearable ActiGraph monitoring with AI-driven skeletal recognition technology (iMirror). This adaptive framework differentiates between insomnia phenotypes: daytime moderate-intensity training (HIIT or resistance exercise) is prescribed to enhance sleep drive for those with difficulty falling asleep (DFA), while nighttime relaxation training (yoga or Pilates) targets reduced hyperarousal for those with difficulty maintaining sleep (DMS). By utilizing continuous objective data, the system creates a feedback loop that dynamically adjusts exercise prescriptions (frequency, intensity, and timing), reducing the need for on-site professional supervision and ensuring safe implementation within the participant's familiar home environment. Ultimately, the DREAMS Study establishes a scalable, data-driven model for precision health promotion to inform future policies on sleep health in aging populations.

02

Conditions studied

  • Chronic Insomnia Characterized
  • Difficulty Falling Asleep
  • Difficulty Maintaining Sleep
  • Healthy Aging and Independent Living

Keywords

  • precision health promotion
  • insomnia phenotyping
  • adaptive feedback loop
  • wearable technology
03

In context

Lead sponsor

National Sun Yat-sen University is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 60 years
  • Capable of independent mobility (without the use of assistive devices).4
  • Meeting one of the following sleep disturbance criteria:

Core symptoms of DSM-5 chronic insomnia (self-reported) for ≥ 3 months. Insomnia Severity Index (ISI) ≥ 15 (moderate-to-severe insomnia). Pittsburgh Sleep Quality Index (PSQI) > 5 (poor sleep quality).

  • Basic ability to use a tablet or smartphone (caregivers may assist with login, but exercise must be performed by the participant).
  • Mini-Cog score ≥ 3.
  • Consent to wear wearable devices and participate in data collection.

Exclusion criteria

Exclusion Criteria:

  • Major cardiovascular events within the past 3 months (e.g., acute myocardial infarction, unstable angina), severe heart failure, or uncontrolled hypertension (e.g., SBP ≥ 180 or DBP ≥ 110 mmHg).
  • Severe osteoarticular or neuromuscular diseases that prevent the safe completion of exercise (e.g., recent hip fracture, severe Parkinsonian imbalance).
  • Severe psychiatric disorders or substance use disorders that may affect adherence.
  • Untreated moderate-to-severe obstructive sleep apnea (OSA) with extreme daytime sleepiness (the study will use objective measurements for preliminary screening).
  • Currently receiving structured psychotherapy for insomnia (e.g., CBT-I or BBTi) and not yet stabilized.
  • Severe visual or hearing impairment that prevents following voice or visual instructions.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    AI-Driven Dual-Track Residential Exercise and Physiological Monitoring Arm

    Participants (≥ 60) with chronic insomnia undergo a 12-week home exercise intervention followed by a 12-week follow-up. The system integrates FitMirror AI skeletal recognition for real-time guidance and ActiGraph wearable monitoring for continuous data collection. An adaptive closed-loop mechanism tailors exercise to specific insomnia phenotypes: daytime HIIT or resistance training is prescribed to enhance sleep drive for those with sleep-onset difficulties (DFA), while nighttime yoga or Pilates targets reduced hyperarousal for those with maintenance difficulties (DMS). Effectiveness is evaluated at baseline, 12 weeks, and 24 weeks using linear mixed-effects models to track improvements in multi-dimensional sleep health and functional fitness.

    Device: Fit Mirror-Guided Home-Based Exercise Program

Interventions

  • DeviceFit Mirror-Guided Home-Based Exercise Program

    The DREAMS Study evaluates an AI-driven, home-based, dual-track exercise intervention for community-dwelling older adults (≥ 60) with chronic insomnia. Integrating FitMirror skeletal recognition for real-time guidance and ActiGraph wearable monitoring for continuous data collection, the system creates a closed-loop feedback mechanism to optimize sleep health. The intervention is tailored to insomnia phenotypes: daytime HIIT or resistance training is prescribed to enhance sleep drive (targeting sleep-onset difficulties), while nighttime yoga or Pilates targets reduced hyperarousal (targeting sleep-maintenance difficulties). Using a quasi-experimental design, the study measures improvements in multi-dimensional sleep health and functional fitness at baseline, post-intervention (12 weeks), and follow-up (24 weeks).

06

What researchers measure

Primary outcomes

  1. Multi-dimensional Sleep Health Assessment via Objective Actigraphy and Subjective Diaries

    This study evaluates sleep using Buysse's (2018) Multidimensional Sleep Health framework. To address reviewer concerns regarding distinct units, the following parameters are reported separately: 1) Sleep Efficiency (%) and Duration (min), objectively monitored by ActiGraph wGT3X-BT (7-14 days per stage). 2) Sleep Regularity (min), defined as the standard deviation of the weekly sleep midpoint. 3) Sleep Timing (clock time), representing the average weekly midpoint. 4) Subjective Quality and Daytime Alertness (1-5 scale), captured via daily diaries where lower scores indicate better health. Actigraphy data are processed at 30-second epochs using ActiLife v6.13.3. This dual-track approach monitors how daytime HIIT (building sleep drive) and nighttime relaxation (reducing hyperarousal) affect specific insomnia phenotypes, overcoming the "mismatch" between subjective and objective perception. All metrics are summarized as weekly means

    Time frame: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

  2. Multi-component Functional Physical Fitness Performance

    The specific components of the physical assessment include the 30-second chair stand test to evaluate lower body strength by counting full stands from a seated position, and the 30-second arm curl test to measure upper body strength using 5-pound weights for women or 8-pound weights for men. Flexibility is assessed through the chair sit-and-reach test for the lower body and the back scratch test for the upper body, with distances measured in centimeters to determine the range of motion in the limbs. Agility and dynamic balance are recorded using the 8-foot up-and-go test, which times how quickly a participant can rise from a chair, walk 2.44 meters around a marker, and return to a seated position. Cardiorespiratory endurance is measured using either the 2-minute knee-up test, which counts total repetitions of lifting the knees to a specified height, or the 6-minute walk test, which measures the total distance traveled in meters and can be used to estimate maximal aerobic capacity.

    Time frame: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

Secondary outcomes

  1. Body Composition Analysis via Multi-Frequency Bioelectrical Impedance Analysis

    Measurements are conducted in the morning, 3 hours post-meal, after emptying the bladder and avoiding vigorous exercise to prevent electrolyte and water fluctuations. Participants stand barefoot on the Tanita MC-780MA Multi-frequency Segmental Body Composition Analyzer, holding hand electrodes with arms positioned away from the torso. This assessment provides comprehensive data on basal metabolism, visceral fat index, body water, and segmental fat/muscle mass. Critically, it analyzes the Skeletal Muscle Mass Index (SMI), a key indicator for sarcopenia.

    Time frame: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

  2. Self-Reported Demographic and Clinical Health Profile

    Participants self-complete a structured questionnaire covering demographic variables (gender, height, weight, education level) and clinical history, including comorbidities such as hypertension, diabetes, cardiovascular disease, COPD, asthma, cancer, sleep apnea, stroke, or brain injury. The profile also records the frequency of lifestyle habits (smoking, alcohol, and exercise categorized as none, weekly, monthly, or yearly) and any past diagnosis of psychiatric disorders. This data ensures proper screening and baseline characterization of the study population.

    Time frame: Collected at Baseline (T0).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07513584
Lead sponsor
National Sun Yat-sen University
Responsible party
Sponsor
First posted
Apr 7, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Apr 7, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion